DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
9.91
-0.54 (-5.12%)
Oct 6, 2026, 1:55 PM EDT - Market open
DBV Technologies Employees
DBV Technologies had 170 employees as of June 30, 2026. The number of employees increased by 61 or 55.96% compared to the same quarter last year.
Employees
170
Change
61
Growth
55.96%
Revenue / Employee
$29,624
Profits / Employee
-$1,034,982
Market Cap
615.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 170 | 61 | 55.96% | 170 | 0 |
| Mar 31, 2026 | 161 | 55 | 51.89% | 161 | 0 |
| Dec 31, 2025 | 126 | 16 | 14.55% | 125 | 1 |
| Sep 30, 2025 | 117 | 9 | 8.33% | 117 | 0 |
| Jun 30, 2025 | 109 | 3 | 2.83% | 109 | 0 |
| Mar 31, 2025 | 106 | 1 | 0.95% | 106 | 0 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Sep 30, 2024 | 108 | 11 | 11.34% | 108 | 0 |
| Jun 30, 2024 | 106 | 18 | 20.45% | 106 | 0 |
| Mar 31, 2024 | 105 | 17 | 19.32% | 105 | 0 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Sep 30, 2023 | 97 | 12 | 14.12% | 97 | 0 |
| Jun 30, 2023 | 88 | 1 | 1.15% | 88 | 0 |
| Mar 31, 2023 | 88 | 0 | - | 88 | 0 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Sep 30, 2022 | 85 | -7 | -7.61% | 85 | 0 |
| Jun 30, 2022 | 87 | -10 | -10.31% | 87 | 0 |
| Mar 31, 2022 | 88 | -16 | -15.38% | 88 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Prime Medicine | 146 |
| Aura Biosciences | 113 |
| OmniAb | 89 |
| Silence Therapeutics | 88 |
| Crescent Biopharma | 69 |
| Zevra Therapeutics | 61 |
| Shattuck Labs | 40 |
| Climb Bio | 29 |
DBVT News
- 6 days ago - DBV Technologies Files FDA Biologics License Application for Viaskin Peanut Patch (DBVT) - GuruFocus
- 6 days ago - DBV Seeks FDA Approval For VIASKIN Peanut Patch In Young Children - Nasdaq
- 6 days ago - DBV Submits BLA For VIASKIN Peanut Patch In Children With Peanut Allergy - Nasdaq
- 6 days ago - DBV Technologies submits BLA to FDA for Viaskin Peanut Patch - TheFly
- 6 days ago - DBV Technologies S.A.: DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN Peanut Patch in Children Aged 4-7 Years - Finanz Nachrichten
- 6 days ago - DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years - GlobeNewsWire
- 20 days ago - DBV Technologies Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 27 days ago - DBV Technologies Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts